A clinical SPECT imaging study on five patients with Kaposi's sarcoma (KS) using N-TIMP-2-DTPA labeled with 111In was disappointing in that none of the patients showed significant uptake in KS lesions [135]. This evidence concerns the gene TIMP2 and Kaposi's sarcoma.